Business ❯ Market Analysis ❯ Stock Performance ❯ Analyst Ratings

Price Targets

DexCom Hits Five-Year Low as GLP-1 Fears Overpower Strong Quarterly Results

Investor confidence is sliding due to regulatory scrutiny, litigation, margin pressures and growing GLP-1 adoption.

Norway’s $2 Trillion Wealth Fund Opposes Musk’s $1 Trillion Tesla Pay Ahead of Vote

AI Investment Split Widens: Goldman Backs Buildout as Citi Puts $1 Trillion Price on OpenAI Plans

Berkshire Hathaway Discloses $1.6 Billion UnitedHealth Stake in Q2 Filing

AMD Stock Rally Accelerates With New AI Chips and Partnerships